We provide you with 20 years of free, institutional-grade data for IMRX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of IMRX. Explore the full financial landscape of IMRX stock.
| Reported Date | CIK | Ticker | Type |
|---|
Immuneering Corporation(NASDAQ:IMRX) 
Immuneering Corporation provides genetic, genomic, and proteomic data analysis services for pharmaceutical companies to generate biological insights that enhance the clinical and commercial success of medicines. The company was incorporated in 2008 and is based in Cambridge, Massachusetts.
Website: https://immuneering.com/
Founded: 2008
CEO / Co-Founder: Ben Zeskind
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about IMRX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.